Clinical and molecular genetic risk determinants in adult long QT syndrome type 1 and 2 patients : Koponen et al. Follow-up of adult LQTS patients.

about

Clinical and molecular genetic risk determinants in adult long QT syndrome type 1 and 2 patients : Koponen et al. Follow-up of adult LQTS patients.

Item

http://www.wikidata.org/entity/Q55053440

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Clinical and molecular genetic ...... low-up of adult LQTS patients.

@en

Clinical and molecular genetic ...... low-up of adult LQTS patients.

@nl

type

Item

label

Clinical and molecular genetic ...... low-up of adult LQTS patients.

@en

Clinical and molecular genetic ...... low-up of adult LQTS patients.

@nl

prefLabel

Clinical and molecular genetic ...... low-up of adult LQTS patients.

@en

Clinical and molecular genetic ...... low-up of adult LQTS patients.

@nl

P1476

Clinical and molecular genetic ...... low-up of adult LQTS patients.

@en

P2093

Annukka M Tuiskula

http://www.w3.org/2001/XMLSchema#string

Annukka Marjamaa

http://www.w3.org/2001/XMLSchema#string

Heikki Swan

http://www.w3.org/2001/XMLSchema#string

Kimmo Kontula

http://www.w3.org/2001/XMLSchema#string

Kirsi Piippo

http://www.w3.org/2001/XMLSchema#string

Lauri Toivonen

http://www.w3.org/2001/XMLSchema#string

Matti Viitasalo

http://www.w3.org/2001/XMLSchema#string

Mikael Koponen

http://www.w3.org/2001/XMLSchema#string

Päivi J Laitinen-Forsblom

http://www.w3.org/2001/XMLSchema#string

P2860

2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the

Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias.

Risk stratification in the long-QT syndrome.

Implantable cardioverter defibrillator in high-risk long QT syndrome patients.

Association of long QT syndrome loci and cardiac events among patients treated with beta-blockers.

Clinical aspects of type-1 long-QT syndrome by location, coding type, and biophysical function of mutations involving the KCNQ1 gene.

Mutation-specific risk in two genetic forms of type 3 long QT syndrome.

Beta-blocker efficacy in high-risk patients with the congenital long-QT syndrome types 1 and 2: implications for patient management

Risk factors for recurrent syncope and subsequent fatal or near-fatal events in children and adolescents with long QT syndrome

Risk of syncope in family members who are genotype-negative for a family-associated long-QT syndrome mutation

P2888

s12881-018-0574-0

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12881-018-0574-0

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Veikko Salomaa

Aki S Havulinna

P577

2018-04-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1103128686

http://www.w3.org/2001/XMLSchema#string

P698

29622001

http://www.w3.org/2001/XMLSchema#string

P932

5887247

http://www.w3.org/2001/XMLSchema#string